224 related articles for article (PubMed ID: 33126410)
1. Osteoporosis: From Molecular Mechanisms to Therapies 2.0.
Tang CH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126410
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis: From Molecular Mechanisms to Therapies.
Tang CH
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979046
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis: From Molecular Mechanisms to Therapies 3.0.
Tang CH
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884529
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on osteoporosis therapies.
Cairoli E; Zhukouskaya VV; Eller-Vainicher C; Chiodini I
J Endocrinol Invest; 2015 Mar; 38(3):303-11. PubMed ID: 25577263
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis drugs. Current and future options.
Mayo Clin Health Lett; 2012 Nov; 30(11):7. PubMed ID: 23795362
[No Abstract] [Full Text] [Related]
6. Effects of osteoporosis medications on bone quality.
Benhamou CL
Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Treatment of Bone Loss.
Pang R; Xia W
Curr Pharm Des; 2017; 23(41):6298-6301. PubMed ID: 28521692
[TBL] [Abstract][Full Text] [Related]
8. New understanding and treatments for osteoporosis.
Mazziotti G; Bilezikian J; Canalis E; Cocchi D; Giustina A
Endocrine; 2012 Feb; 41(1):58-69. PubMed ID: 22180055
[TBL] [Abstract][Full Text] [Related]
9. [Bone micro-structural changes following osteoporotic drug treatment].
Mori S
Clin Calcium; 2013 Jul; 23(7):1027-33. PubMed ID: 23811592
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis therapy: a novel insight from natural homeostatic system in the skeleton.
Sugiyama T; Kim YT; Oda H
Osteoporos Int; 2015 Feb; 26(2):443-7. PubMed ID: 25288445
[TBL] [Abstract][Full Text] [Related]
11. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
[TBL] [Abstract][Full Text] [Related]
12. Established and forthcoming drugs for the treatment of osteoporosis.
Lems WF; den Heijer M
Neth J Med; 2013 May; 71(4):188-93. PubMed ID: 23723112
[TBL] [Abstract][Full Text] [Related]
13. Bone quality and osteoporosis therapy.
Martin RM; Correa PH
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):186-99. PubMed ID: 20485908
[TBL] [Abstract][Full Text] [Related]
14. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
Riggs BL; Parfitt AM
J Bone Miner Res; 2005 Feb; 20(2):177-84. PubMed ID: 15647810
[TBL] [Abstract][Full Text] [Related]
15. Effects of bisphosphonates on osteoporosis: Focus on zoledronate.
Oryan A; Sahvieh S
Life Sci; 2021 Jan; 264():118681. PubMed ID: 33129881
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of anabolic therapies for osteoporosis.
Canalis E; Giustina A; Bilezikian JP
N Engl J Med; 2007 Aug; 357(9):905-16. PubMed ID: 17761594
[No Abstract] [Full Text] [Related]
17. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development.
Li H; Xiao Z; Quarles LD; Li W
Curr Med Chem; 2021; 28(8):1489-1507. PubMed ID: 32223730
[TBL] [Abstract][Full Text] [Related]
18. One year in review 2018: progress in osteoporosis treatment.
Figliomeni A; Signorini V; Mazzantini M
Clin Exp Rheumatol; 2018; 36(6):948-958. PubMed ID: 30526765
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of action of anticatabolic drugs used in osteoporosis therapy].
Kryśkiewicz E; Lorenc RS
Endokrynol Pol; 2009; 60(2):134-44. PubMed ID: 19396757
[TBL] [Abstract][Full Text] [Related]
20. Side effects of drugs for osteoporosis and metastatic bone disease.
Skjødt MK; Frost M; Abrahamsen B
Br J Clin Pharmacol; 2019 Jun; 85(6):1063-1071. PubMed ID: 30192026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
